![]()
|
|
||||||||
(Received for publication, January 3, 1996, and in revised form, March 12, 1996)
From the Departments of Epoxyeicosatrienoic acids (EETs) are synthesized
by cytochrome P-450 monooxygenases and released into the blood. When
taken up by vascular endothelial and smooth muscle cells, the EETs are
primarily esterified to phospholipids or converted to
dihydroxyeicosatetraenoic acids (DHETs) and released. In the present
studies, radiolabeled 8,9-, 11,12-, and 14,15-DHETs released into the
medium from vascular smooth muscle cells were isolated and incubated
for 4-16 h with cultured bovine aortic endothelial cells. The uptake
ranged from 2 to 50% for the three regioisomers. Hydrolysis of the
endothelial lipids and gas chromatographic-mass spectral analyses of
the products indicated that all three DHET regioisomers were
incorporated intact into phosphatidylcholine and phosphatidylinositol.
Similar incubations with EETs confirmed that small amounts of DHETs
were also esterified to endothelial phospholipids. These studies
indicate that DHETs are incorporated into phospholipids either at the
time of EET conversion to DHET or upon release and re-uptake of DHETs.
Beside demonstrating for the first time that fatty acid diols are
incorporated intact into endothelial lipids, these studies raise the
possibility that both EETs and DHETs remain long enough in the vascular
wall to produce chronic vasoactive effects.
Volume 271, Number 24,
Issue of June 14, 1996
pp. 14001-14009
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
,
and
¶
Internal Medicine,
¶ Biochemistry, and
Pharmacology, University of Iowa
College of Medicine, Iowa City, Iowa 52242
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. J. Corenblum, V. E. Wise, K. Georgi, B. D. Hammock, P. A. Doris, and M. Fornage Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat Hypertension, February 1, 2008; 51(2): 567 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha} Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. You, E. M. Golding, and R. M. Bryan Jr. Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1077 - H1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fornage, E. Boerwinkle, P. A. Doris, D. Jacobs, K. Liu, and N. D. Wong Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study Circulation, January 27, 2004; 109(3): 335 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Kaduce, X. Fang, S. D. Harmon, C. L. Oltman, K. C. Dellsperger, L. M. Teesch, V. R. Gopal, J. R. Falck, W. B. Campbell, N. L. Weintraub, et al. 20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells J. Biol. Chem., January 23, 2004; 279(4): 2648 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.-C. Lee, and M. VanRollins Cytochrome P-450 Epoxygenase Metabolites of Docosahexaenoate Potently Dilate Coronary Arterioles by Activating Large-Conductance Calcium-Activated Potassium Channels J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 768 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming Cytochrome P450 and Vascular Homeostasis Circ. Res., October 26, 2001; 89(9): 753 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, C. L. Oltman, T. Lu, H.-C. Lee, K. C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BKCa channels Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2430 - H2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Weintraub, X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2098 - H2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, S. A. Moore, L. L. Stoll, G. Rich, T. L. Kaduce, N. L. Weintraub, and A. A. Spector 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2113 - H2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Oltman, N. L. Weintraub, M. VanRollins, and K. C. Dellsperger Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids Are Potent Vasodilators in the Canine Coronary Microcirculation Circ. Res., November 2, 1998; 83(9): 932 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Harder, N. J. Alkayed, A. R. Lange, D. Gebremedhin, and R. J. Roman Functional Hyperemia in the Brain : Hypothesis for Astrocyte-Derived Vasodilator Metabolites Stroke, January 1, 1998; 29(1): 229 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Weintraub, X. Fang, T. L. Kaduce, M. VanRollins, P. Chatterjee, and A. A. Spector Potentiation of Endothelium-Dependent Relaxation by Epoxyeicosatrienoic Acids Circ. Res., August 19, 1997; 81(2): 258 - 267. [Abstract] [Full Text] |
||||
![]() |
M. Sandberg, C. Hassett, E. T. Adman, J. Meijer, and C. J. Omiecinski Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic Polymorphisms J. Biol. Chem., September 8, 2000; 275(37): 28873 - 28881. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, T. L. Kaduce, N. L. Weintraub, S. Harmon, L. M. Teesch, C. Morisseau, D. A. Thompson, B. D. Hammock, and A. A. Spector Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells. IMPLICATIONS FOR THE VASCULAR EFFECTS OF SOLUBLE EPOXIDE HYDROLASE INHIBITION J. Biol. Chem., April 27, 2001; 276(18): 14867 - 14874. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Salvail, M. Cloutier, and E. Rousseau Functional reconstitution of an eicosanoid-modulated Cl- channel from bovine tracheal smooth muscle Am J Physiol Cell Physiol, March 1, 2002; 282(3): C567 - C577. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |